Senior Director of Product Management, Oncology Innovations
NateraSalary not specified
- Full Time
- Senior (5 to 8 years)
Not SpecifiedCompensation
Expert & Leadership (9+ years)Experience Level
Full TimeJob Type
UnknownVisa
BiotechnologyIndustries
Requirements
Candidates should have a minimum of 8-10 years of experience in site onboarding, market enablement, institutional engagement, commercial operations, or related functions within biotech/pharma, with oncology, hematology, or cell therapy experience being strongly preferred. They should possess a proven track record in designing and executing treatment center onboarding frameworks for complex therapies such as CAR-T, allogeneic transplant, or gene therapy, including experience in developing SOPs and training materials.
Responsibilities
The Lead, Site Onboarding and Market Enablement will oversee the implementation of Orca Bio’s treatment center onboarding strategy, including certification processes and readiness milestones. They will establish a centralized onboarding command center to drive accountability and coordinate cross-functional efforts, and collaborate with commercial, clinical, medical, regulatory, quality, supply chain, and operational teams. The role involves building and maintaining relationships with treatment center leadership, designing institutional engagement strategies, and leading a growing team to ensure operational readiness for ORCA-T administration.
Skills
Site Onboarding
Operational Readiness
Treatment Center Certification
SOP Development
Cross-functional Collaboration
Team Management
Process Implementation
Regulatory Standards
Quality Standards
Orca Bio
Develops and commercializes cell therapies
About Orca Bio
Orca Bio operates in the biotechnology sector, specifically focusing on cell therapies that utilize the body's own cells to treat diseases. The company works to enhance these therapies, aiming to make them safer and more effective for patients. Orca Bio's products are primarily used by healthcare providers who administer these therapies to patients as part of their treatment plans. Unlike many competitors, Orca Bio emphasizes a strong team culture and values communication with stakeholders, keeping them informed about the company's progress and developments. The goal of Orca Bio is to improve patient outcomes through advanced cell therapies, addressing conditions that currently have limited treatment options.
Key Metrics
Menlo Park, CaliforniaHeadquarters
2016Year Founded
$186.8MTotal Funding
SERIES_DCompany Stage
Biotechnology, HealthcareIndustries
51-200Employees